Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns.

Lea IA, Jackson MA, Li X, Bailey S, Peddada SD, Dunnick JK.

Carcinogenesis. 2007 Sep;28(9):1851-8. Epub 2007 Aug 11. Review.

2.

Genetic and epigenetic alterations of the LKB1 gene and their associations with mutations in TP53 and EGFR pathway genes in Korean non-small cell lung cancers.

Lee SM, Choi JE, Na YK, Lee EJ, Lee WK, Choi YY, Yoon GS, Jeon HS, Kim DS, Park JY.

Lung Cancer. 2013 Aug;81(2):194-9. doi: 10.1016/j.lungcan.2013.04.013. Epub 2013 May 10.

PMID:
23664447
3.

Alterations of the TP53 gene in gastric and esophageal carcinogenesis.

Bellini MF, Cadamuro AC, Succi M, Proença MA, Silva AE.

J Biomed Biotechnol. 2012;2012:891961. doi: 10.1155/2012/891961. Epub 2012 Aug 7. Review.

4.

Genetic pathways to colorectal cancer.

Lea IA, Jackson MA, Dunnick JK.

Mutat Res. 2009 Nov 2;670(1-2):96-8. doi: 10.1016/j.mrfmmm.2009.06.011. Epub 2009 Jul 1.

5.

Genetic pathways of two types of gastric cancer.

Tahara E.

IARC Sci Publ. 2004;(157):327-49. Review.

PMID:
15055305
6.

Infrequent frameshift mutations of polynucleotide repeats in multiple primary cancers affecting the esophagus and other organs.

Iwaya T, Maesawa C, Nishizuka S, Suzuki Y, Sakata K, Sato N, Ikeda K, Koeda K, Ogasawara S, Otsuka K, Kimura Y, Aoki K, Ishida K, Saito K, Tamura G.

Genes Chromosomes Cancer. 1998 Dec;23(4):317-22.

PMID:
9824204
7.

APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q.

Arnold CN, Goel A, Niedzwiecki D, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR.

Cancer Biol Ther. 2004 Oct;3(10):960-4. Epub 2004 Oct 27.

PMID:
15326380
8.

p53 mutations in human lung tumors.

Miller CW, Simon K, Aslo A, Kok K, Yokota J, Buys CH, Terada M, Koeffler HP.

Cancer Res. 1992 Apr 1;52(7):1695-8.

9.

Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer.

Morris VK, Lucas FA, Overman MJ, Eng C, Morelli MP, Jiang ZQ, Luthra R, Meric-Bernstam F, Maru D, Scheet P, Kopetz S, Vilar E.

Ann Oncol. 2014 Oct;25(10):2008-14. doi: 10.1093/annonc/mdu252. Epub 2014 Jul 9.

10.

Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.

Reifenberger J, Wolter M, Knobbe CB, Köhler B, Schönicke A, Scharwächter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.

Br J Dermatol. 2005 Jan;152(1):43-51.

PMID:
15656799
11.

PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.

Day FL, Jorissen RN, Lipton L, Mouradov D, Sakthianandeswaren A, Christie M, Li S, Tsui C, Tie J, Desai J, Xu ZZ, Molloy P, Whitehall V, Leggett BA, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Busam D, Zhao Q, Strausberg RL, Gibbs P, Sieber OM.

Clin Cancer Res. 2013 Jun 15;19(12):3285-96. doi: 10.1158/1078-0432.CCR-12-3614. Epub 2013 Apr 30.

12.

P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.

Lasky T, Silbergeld E.

Environ Health Perspect. 1996 Dec;104(12):1324-31.

13.

Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.

Libè R, Groussin L, Tissier F, Elie C, René-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C, Bertherat J.

Clin Cancer Res. 2007 Feb 1;13(3):844-50.

14.

Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.

Marsit CJ, Hasegawa M, Hirao T, Kim DH, Aldape K, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT.

Cancer Res. 2004 Dec 1;64(23):8702-7.

15.

Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.

Popović Hadzija M, Radosevic S, Kovacević D, Lukac J, Hadzija M, Spaventi R, Pavelić K, Kapitanović S.

Mutat Res. 2004 Apr 14;548(1-2):61-73.

PMID:
15063137
16.

Genetic and epigenetic changes in the APC gene in sporadic colorectal carcinoma with synchronous adenoma.

Kim JC, Koo KH, Roh SA, Cho YK, Kim HC, Yu CS, Kim HJ, Kim JS, Cho MK.

Int J Colorectal Dis. 2003 May;18(3):203-9. Epub 2002 Dec 14.

PMID:
12673484
17.
18.

Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.

Marchetti A, Pellegrini S, Sozzi G, Bertacca G, Gaeta P, Buttitta F, Carnicelli V, Griseri P, Chella A, Angeletti CA, Pierotti M, Bevilacqua G.

Br J Cancer. 1998 Jul;78(1):73-8.

19.

Molecular genetic analysis of 103 sporadic colorectal tumours in Czech patients.

Vasovcak P, Pavlikova K, Sedlacek Z, Skapa P, Kouda M, Hoch J, Krepelova A.

PLoS One. 2011;6(8):e24114. doi: 10.1371/journal.pone.0024114. Epub 2011 Aug 25.

20.

Supplemental Content

Support Center